Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Priya Nigam

Why BofA Downgrades DocuSign Despite Healthy Q1 Print

Although Docusign Inc (NASDAQ:DOCU) reported healthy first-quarter results, its full-year billings guidance was disappointing, reflecting “choppy execution” according to BofA Securities.

The DocuSign Analyst: Brad Sills downgraded the rating for DocuSign from Buy to Neutral, while reducing the price target from $120 to $72.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.